Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Vomiting × dolasetron × Clear all

Phase

Status

Sponsor Class

OTHER 3 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Vomiting 1 Neoplasms 1 Nausea 1

Interventions

Dexamethasone 10 Palonosetron 8 casopitant 6 Granisetron 6 Ondansetron 5 Aprepitant 5 netupitant, palosentron drug combination 3 Duration of Therapy 2 netupitant 1 dolasetron 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 alizapride 1 Tropisetron 1 Tablets 1 NDC80 protein, human 1 Metoclopramide 1 Injections, Intravenous 1 Exercise 1 Docetaxel 1 Cyclophosphamide 1 Calcium Dobesilate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01636947 2018-09-25

KMEC

Merck Sharp & Dohme LLC

Phase 4 Completed

494 enrolled 14 charts

Nausea, Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon ⚡